David Patience

David Patience currently serves as the Chief Financial Officer at TriSalus Life Sciences, a position held since July 2025. Prior to this role, David held various leadership positions including Chief Financial Officer at Accelerate Diagnostics from January 2018 to June 2025, as well as roles in business development and strategic finance. David's extensive experience includes membership on the Board of Directors for the Arizona BioIndustry Association from January 2020 to June 2025, and previous positions at Morgan Stanley and Continental Advisors, spanning investment banking and equity research. Educational qualifications include an M.B.A. from The University of Chicago Booth School of Business, with concentrations in accounting, econometrics, statistics, entrepreneurship, and finance, and a BA in finance from the University of Colorado Boulder.